This investigation studied the antiviral activity of, and the utilization of viruses as substrates by, bacteria. Reovirus type 3 and bacterial species representative of those endemic to sewage, aquatic, and terrestrial habitats were used in the model systems. Culture supernatants from Bacillus subtilis maintained for 5 days in a minimal salts medium displayed antiviral activity, but supernatants from Escherichia coli or Serratia marcescens did not. Both live and toluene-killed cells reduced the inactivation of reovirus during 4 days of incubation at 23 ± 2 °C. This protective effect was more pronounced with killed than with live cells of B. subtilis, confirming the presence of an antiviral component(s) in this species and indicating that the component(s) was metabolic in origin. When reovirus was presented to these bacteria as a sole source of carbon, some growth (determined spectrophotometrically) of B. subtilis and S. marcescens occurred with reovirus concentrations of 3.1 × 106 and 8.2 × 106 mean tissue culture infective dose-fifty∙mL−1, respectively. Growth of S. marcescens did not occur with a reovirus concentration of 8.0 × 104 mean tissue culture infective dose-fifty∙mL−1, nor did that of E. coli with any virus concentration used in this study. Adsorption of reovirus on kaolinite was enhanced by the culture supernatant from S. marcescens and on montmorillonite, albeit to a lesser extent, by that from E. coli. The effect of culture supernatants from B. subtilis on the adsorption of reovirus on clay minerals could not be determined, as a result of the antiviral component produced by these cells. The virus was not adsorbed on the bacteria.
Log10 50 Percent Tissue Culture Infective Dose
